PTK2 and breast carcinoma: Additionally, stromal FN1 promotes both FAK/RAS/MEK/ERK and FAK/PI3K/Akt pathways in breast cancer cells, leading to estrogen receptor-α phosphorylation and subsequent tamoxifen sensitivity (Figure 3) (Pontiggia et al., 2012).